Quest Diagnostics Incorporated
DGX
$178.03
-$0.81-0.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.74% | 12.58% | 9.38% | 6.70% | 2.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.74% | 12.58% | 9.38% | 6.70% | 2.60% |
| Cost of Revenue | 12.97% | 12.29% | 9.40% | 6.71% | 3.20% |
| Gross Profit | 15.31% | 13.18% | 9.34% | 6.68% | 1.42% |
| SG&A Expenses | 12.61% | 12.93% | 8.57% | 7.31% | -3.83% |
| Depreciation & Amortization | 31.62% | 31.25% | 23.42% | 17.59% | -2.50% |
| Other Operating Expenses | 300.00% | -- | 200.00% | 0.00% | 90.00% |
| Total Operating Expenses | 13.24% | 12.71% | 9.45% | 6.98% | 1.82% |
| Operating Income | 16.79% | 11.83% | 8.95% | 5.06% | 7.64% |
| Income Before Tax | 16.92% | 13.62% | 5.75% | 3.29% | 10.95% |
| Income Tax Expenses | 22.86% | 16.53% | 6.83% | 10.08% | 20.10% |
| Earnings from Continuing Operations | 15.28% | 12.81% | 5.45% | 1.43% | 8.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.33% | -8.00% | 3.77% | 7.41% | 12.50% |
| Net Income | 15.22% | 13.10% | 6.03% | 1.99% | 10.22% |
| EBIT | 16.79% | 11.83% | 8.95% | 5.06% | 7.64% |
| EBITDA | 17.59% | 13.85% | 10.56% | 6.84% | 6.87% |
| EPS Basic | 14.87% | 13.00% | 6.43% | 2.56% | 11.04% |
| Normalized Basic EPS | 11.71% | 7.78% | 4.50% | 2.45% | 9.07% |
| EPS Diluted | 15.74% | 13.90% | 7.63% | 3.81% | 10.73% |
| Normalized Diluted EPS | 11.26% | 7.57% | 4.54% | 2.70% | 9.78% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | -0.45% | -0.67% | -0.67% |
| Average Diluted Shares Outstanding | 0.44% | 0.22% | -0.44% | -0.88% | -1.32% |
| Dividend Per Share | 6.42% | 6.16% | 5.90% | 5.63% | 6.09% |
| Payout Ratio | -0.08% | -0.06% | -0.01% | 0.03% | -0.04% |